Chief Executive Officer

Chief Financial Officer and Chief Operating Officer

Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium

Liquidia Technologies call volume above normal and directionally bullish

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Director, Pricing & Access Analytics

Liquidia Corporation is dedicated to developing innovative therapies for patients with pulmonary hypertension. The Director, Pricing & Access Analytics will leverage advanced analytical techniques to inform pricing and access decisions, support contract negotiations, and optimize profitability across the company's portfolio.

Sign up with Google

Sign in with Google